Skip to main content
We help emerging biotechs, established pharma, and investment firms advance vital programs with confidence from early preclinical development through approval. We provide rapid access to a curated global network of senior consultants with deep expertise in CMC, Regulatory Affairs, Quality, Nonclinical, and Clinical Development who have already delivered in complex, highly regulated environments where timelines and capital are on the line.



Our Business Development & Due Diligence Consulting team supports buy-side and sell-side transactions and builds tailored development strategies aligned to corporate goals. In parallel, our Biopharmaceutical Digital Innovation Group offers experience-led guidance on sustainable approaches to data transfer and integration, knowledge management, smart manufacturing, and the considered use of generative AI.



We assemble the right expertise at the right moment, adapt to real-world constraints, and stay engaged until outcomes are delivered.

 
No data available
No data available
Nuclera is a US and UK-based biotechnology company driven by the mission to better human health by making proteins accessible. Nuclera is enabling life science researchers to obtain active proteins from DNA in 48 hours through its benchtop eProtein DiscoveryTM platform.
Website: https://www.nuclera.com
Contact: [email protected]
Watch our showcase video: https://www.nuclera.com/resource-library/video-intro-to-eprotein-discovery/
Heptares creates new medicines targeting previously undruggable or challenging GPCRs, a superfamily of receptors linked to many diseases. We are pioneering a structure-based drug design approach to GPCRs, leveraging proprietary technologies for protein stabilisation, structure determination, and fragment-based discovery. Our partners include Shire, AstraZeneca, MedImmune and Takeda. Our objective is to build a broad pipeline of novel medicines to transform the treatment of serious diseases, including Alzheimer’s disease, Parkinson’s disease, schizophrenia, depression, chronic insomnia, addiction, migraine and diabetes.
No data available
One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity. Through providing the local, UK-wide and international connectivity, One Nucleus seeks to enable our members to maximise their performance. This support helps them achieve, or better still exceed, the goals they have set for themselves. Biomedical and Healthcare R&D have always been impactful in driving social and economic progress. In an increasingly outsourced, collaborative and multi-disciplinary sector, bringing the best people together is key to translating great innovation into great products that markedly improve patient outcomes and drive economic development. Attracting and enabling the best people to engage with is at the heart of the One Nucleus team ethos and what we continually strive to deliver. https://www.onenucleus.com

https://www.onhelix.com/
cancer profiling, diagnostics
new antibiotics class
Optimum is an international strategic healthcare communications firm, specialising in investor relations, corporate and financial communications. Our team of healthcare specialists, based in London and New York, have worked together for many years. We are experienced and trusted advisors to some of the world's most exciting public and private companies across pharmaceuticals, medtech, biotech, digital health and healthcare services, large and small.
Watch our Member Showcase Video https://bit.ly/3FFKIIz